Q32 Bio (QTTB) Asset Utilization Ratio (2018 - 2024)

Q32 Bio's (QTTB) quarterly Asset Utilization Ratio came in at 0.01 in Q3 2024, down 120.87% year-on-year from 0.06 in Q4 2023, and down 429.49% quarter-over-quarter from 0.0 in Q2 2024.

Q32 Bio (QTTB) Asset Utilization Ratio (2018 - 2024) Analysis & Trends

Q32 Bio's Asset Utilization Ratio history runs 7 years deep, the most recent figure standing at 0.01 for Q3 2024.

  • On a quarterly basis, Asset Utilization Ratio fell 120.87% year-over-year to 0.01 in Q3 2024; TTM through Sep 2024 was 0.01, a 120.87% decrease from a year earlier, with the FY2025 full-year figure at 0.7, changed N/A from the prior year.
  • Asset Utilization Ratio fell to 0.01 in Q3 2024 per QTTB's latest filing, from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.15 in Q4 2021 and bottomed at 0.01 in Q3 2024.
  • The 5-year median for Asset Utilization Ratio is 0.02 (2022), against an average of 0.05.
  • Across the five-year window, Asset Utilization Ratio surged 1804.26% in 2021 and plunged 120.87% in 2024, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.01 in 2020, then jumped by 1298.06% to 0.15 in 2021, then plunged by 91.49% to 0.01 in 2022, then surged by 444.15% to 0.07 in 2023, then tumbled by 116.73% to 0.01 in 2024.
  • Per Business Quant, the three latest QTTB Asset Utilization Ratio figures stand at 0.01 (Q3 2024), 0.0 (Q2 2024), and 0.04 (Q1 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Q32 Bio 225.00 Mn 174.25 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 -0.01
Jun 30, 2024 0.00
Mar 31, 2024 0.04
Dec 31, 2023 0.07
Sep 30, 2023 0.06
Jun 30, 2023 0.04
Mar 31, 2023 0.03
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
Mar 31, 2022 0.02
Dec 31, 2021 0.15
Sep 30, 2021 0.14
Jun 30, 2021 0.13
Mar 31, 2021 0.13
Dec 31, 2020 0.01
Sep 30, 2020 0.01
Jun 30, 2020 0.01
Mar 31, 2020 0.01
Dec 31, 2019 0.01